Status:
COMPLETED
Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Choroidal Neovascularization
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
To evaluate the effect of bevacizumab for treatment of non-AMD choroidal neovascularization (CNV); eg:angioid streaks, ocular histoplasmosis, high myopia, idiopathic,etc
Eligibility Criteria
Inclusion
- Cases with subfoveal or juxtafoveal CNV due to a non-AMD related cause.
Exclusion
- Evidence of AMD
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00370786
Start Date
November 1 2005
End Date
February 1 2008
Last Update
July 11 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamid Ahmadieh, MD
Tehran, Tehran Province, Iran, 16666